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The American University in Cairo 
ABSTRACT 
Induced Pluripotent Stem Cells Derived From Mouse Germ Cells 
By: Nora Khan 
Under the supervision of: Dr. Asma Amleh 
While embryonic stem cells are well known to give rise to tissues comprising all three 
germ layers, only recently was it found that embryonic-like stem cells could be 
derived from the postnatal mice testis in culture. Embryonic-like stem cells from 
postnatal testes have shown that they can undertake most if not all, the functions of 
embryonic stem cells. Most recent reports have demonstrated that somatic cells can be 
induced to pluripotent stem cells, mostly with the addition of genes. However, the aim 
of this work is to explore the potential of testicular cells to become pluripotent, 
including expression of pluripotency-associated genes, and embryonic stem cells 
morphology, without the addition of genes. 
To accomplish our aim, we have sacrificed 15 CD-1 Swiss albino mice (8-10 weeks) 
and harvested cells from the testes using both mechanical and enzymatic digestion 
technique to generate single cell suspension. Isolated cells from the testes at day 1 
along with embryonic-like stem cells at day 14 have been characterized via Reverse 
Transcription - Polymerase Chain Reaction (RT-PCR) using germ cells marker 
VASA, embryonic stem cells markers Nanog, cripto TDGF1, Esg1, and Thy1. 
Furthermore, Immunophenotyping was performed via Flow Cytometer using 
embryonic-like stem cells marker SOX2, CD 90 (Thy1), CD15 (SSEA-1), CD117 (c-
kit), and CD133.  
Our results showed success in culturing cells harvested from the testes, these cells 
were reprogrammed and had the characteristics of embryonic stem cell. RT-PCR 
results confirmed the expression of VASA gene at day 1; these cells did not express 
embryonic stem cells markers (Nanog, cripto TDGF1, Esg1, and Thy1). However, 
embryonic-like stem cells at day 14 showed the expression of the previously 
mentioned embryonic stem cells markers, and did not express Vasa, which is a germ 
cell marker. Immunophenotyping results showed a noticed elevation in embryonic 
stem cells markers (SOX2, CD 90, CD15, CD117, and CD133) at day 14 compared to 
those at day 1.  
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Here we report that embryonic-like stem cells can be derived from postnatal mice 
testis. However, further studies are required to assure the optimum value of 
embryonic-like stem cells that is dedifferentiated from mice testis before being used 
clinically in human.  
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1. Literature Review 
 
1.1. What are Stem Cells? 
Stem cells are considered primal cells, progenitors to 200 different cell types, 
which is present in the adult body. Stem cells are characterized of self renewal and 
unlimited potency; they have the ability to go through cycles of cell division while 
remaining undifferentiated or differentiating into any mature cell type. As a result 
stem cells are divided into four different types according to their potency; totipotent, 
pluripotent, multipotent and unipotent (Murrell et al., 2005). During cell 
development they become progressively differentiated in order to fulfill a specialized 
function as a somatic cell. Totipotent stem cells are the cells produced from the first 
few division of a fertilized egg.  All embryonic and extraembryonic tissue can only 
rise from zygotes and blastomeres of early morulas. In this stage the cells present are 
called “totipotent”. Morula cells are totipotent which are able to differentiate into any 
tissue including placental tissues. Cells residing in the inner cells mass can only give 
rise to embryonic tissues but not to extraembryonic ones, and these cells are called 
“pluripotent”. Pluripotent stem cells are able to differentiate into the 3 germ layers. 
Moreover, cells in the adult tissues such as adult stem cells are called “multipotent” 
giving rise to cells of closely related family such as hematopoietic stem cells which 
differentiate into white blood cells, platelets, red blood cells, etc. Multipotent stem 
cells also referred as adult stem cells are considered as a repair system for the body, 
which can replace damaged cells. Last, there is the “unipotent” which are stem cells 
than can give rise to one cell lineage, but they still have the property of self-renewal 
which differs them from other non stem cells such as spermatogenic stem cells 
(Avasthi et al., 2008).
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1.2. Types of Stem Cells 
Stem cells are classified into categories: embryonic stem cells and adult stem cells.  
 
1.2.1. Embryonic Stem Cells 
Embryonic stem cells are present at embryo’s developmental stage, this 
developmental stage is known as the blastocyst stage, pluripotent stem cells can be 
derived from such stage. From embryonic stem cells all 3 germ layers can rise: 
mesoderm, endoderm, and ectoderm (Niwa et al., 2000). Embryonic stem cells can be 
maintained in culture and can develop into more than 220 cell types of adult 
differentiated cells when certain growth factors and stimulation is maintained in the 
culture. Besides, maintaining of pluripotency of embryonic stem cells has been 
established in vitro by adding the culture media specific for embryonic stem cells 
growth (Caveleri et al., 2003). The factors that maintain the pluripotency of 
embryonic stem cells is regulated with the aid of transcription factors. Such 
transcription factor is important for the cells to keep its identity, regulate its 
development from the primitive stage to a functional differentiated cell. There are a 
number of proteins, which were discovered, that regulate embryonic stem cells’ 
pluripotency. Some of these proteins are Nanog, Oct4, Klf4, and Sox2 (Wang et al., 
2007). The indefinite ability of embryonic stem cells of self-renewal along with their 
plasticity allowed in vitro generation of different distinct cell types.  
A lot of research has been dedicated to use the characteristics of embryonic 
stem cells and their self-renewal properties in regenerative medicine. One of the main 
aims of researches done in the field of embryonic stem cells is to generate specialized 
cells from embryonic stem cells, which can be used in replacing damaged tissues in 
patients that suffer from different degenerative diseases. Moreover, to accomplish 
success of embryonic stem cells based therapies; the appropriate culture conditions 
must be studied and developed to produce genetically stable cells to avoid adverse 
effects which might follow transplantation such as the formation of tumors that is 
caused from the rapid growth of embryonic stem cells when grown in adult patients. 
(Vazin et al., 2010).  
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1.2.2. Adult Stem Cells 
Adults’ stem cells are considered undifferentiated cells and are also called 
somatic stem cells, it is found in children and adults. To ensure self-renewal, adult 
stem cells undergo two types of cell division: asymmetric division giving rise to a 
daughter stem cells and a progenitor cell, and symmetric division giving rise to two 
daughter stem cells. Progenitor cells are the type of cells, which differentiate into 
mature cells. Regulating the differentiation of adult stem cells has been studied 
revealing the molecular mechanism, which control their self-renewal and 
differentiation including; Bmi-1, Notch, and Wnt signaling (Molofsky et al., 2003). 
First, Bmi-1, which is a transcription repression factor, it was shown to have a role in 
regulating hematopoietic stem cells and neural stem cells (Park et al., 2003). Second, 
the Notch pathways, which have an important role in cell-to-cell communication, this 
involves gene regulation mechanisms which control differentiation process of stem 
cells. Besides, the Wnt signaling pathway which has a role in embryonic development 
including cell fate specification, cell proliferation and cell migration (Beachy et al., 
2003). 
 
There are different types of adult stem cells, hematopoietic stem cells are one 
of these types, and it is present in the bone marrow, cord blood and peripheral blood 
(Verfaillie, 2002). Hematopoietic stem cells are the early precursor cells which 
differentiate to all blood cell types. Hematopoietic stem cells have the ability to 
reconstitute the bone after any depletion, which might be caused by a disease (Orkin 
et al., 2002). The bone marrow is also rich with stromal stem cells; also know as 
mesenchymal stem cells.  Mesenchymal stem cells have the ability to differentiate 
into different cell types including chondrocytes, myocytes, adipocytes, and osteoblast 
(Zuk et al., 2002). Moreover, there are neural stem cells, which is present in the adult 
brain. It was discovered with the discovery of neurogenesis; the birth of new neurons. 
Although the process of neurogenesis has been well established, the presence of true 
self-renewing stem cells in the hippocampus is still debatable (Bull et al., 2005). 
There is also the Olfactory adult stem cells which is harvested from the olfactory 
mucosa cells; the lining of the nose. Another type of adult stem cells is the adipose 
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derived adult stem cells; they can be isolated from fat tissues. Adipose derived stem 
cells have shown their ability to differentiate to bone, fat, and muscle tissues, and they 
are relatively similar to mesenchymal stem cells collected from the bone marrow 
(Zuk et al., 2002). 
1.3. Characteristics of Embryonic Stem Cells 
Embryonic stem cells grow in colonies that are tightly packed together, with a 
defined border at the periphery of each colony. Besides, embryonic stem cells are 
characterized with a high nucleus to cytoplasm ratio. On the molecular level, 
embryonic stem cells express a number of cell surface markers and transcription 
factors such as Oct3/4, TRA antigens, SSEA4, and Nanog (Carpenter et al., 2003). 
Moreover, embryonic stem cells have the ability to differentiate into all three germ 
layers in vivo and in vitro(Reubinoff et al., 2000).   
1.3.1. Embryonic Stem Cells Markers 
Embryonic stem cells markers are considered to be molecules that are 
specifically expressed in the embryonic stem cells. It is critical to understand the 
function of these markers for characterizing embryonic stem cells and studying their 
mechanism of maintenance and self-renewal. This is difficult in some cases as 
embryonic stem cells might share single or multiple markers with other types of cells. 
The marker based flow cytometry technique along with the magnetic cell sorting are 
being used to initially identify and isolate embryonic stem cells (Zhao et al., 2012). 
There are many molecules that are identified to affect the self-renewal and 
pluripotency of embryonic stem cells. Recent studies have discovered a wide range of 
cell surface markers such as proteins that might be involved in a number of signal 
pathways that can control cell fate decision (Prowse et al., 2007). Some of these 
embryonic stem cells surface marker are: 
• Stage Specific Embryonic Antigens (SSEA): 
They were identified by 3 monoclonal antibodies recognizing carbohydrate 
epitopes present with the globo- and lacto- series glycolipids. These carbohydrate-
associated molecules were found to be involved in controlling cell surface interaction 
that is during development (Shamblott et al., 1998).  SSEA1, which is also, know as 
CD15 are expressed on the surface of murine embryo pre-implantation. It was also 
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found on the surface of human germ cells but not in human embryonic stem cells. As 
a result expression of SSEA1 increases in differentiated human cells, and decreases in 
differentiated murine cells (Draper et al., 2002; Henderson et al., 2002). 
 
• Cluster of Differentiation (CD) antigens: 
They are surface proteins that belong to different class such as glycoproteins, 
receptors, integrins, and adhesion molecules. There are different CD antigens that 
identify different types of cells, CD antigens are recognized by antibodies and are 
used as an efficient tool in cell sorting and cell characterization. CD antigens 
associated with embryonic stem cells are CD9, CD24, CD133, CD90, and CD117; 
these markers were found to be expressed in both human and murine embryonic stem 
cells (Sundberg et al., 2009). 
• Cripto TDGF1: 
This gene encodes a growth factor, which is structurally related to epidermal 
growth factor. Cripto act as a co receptor for transforming growth factor β (TGF-β) 
ligands, and it has a critical role during embryogenesis. Studies showed that Cripto 
TDGF1 is expressed in tumors and they have a role in promoting tumourigenesis 
(Gray et al., 2006).   
• Transcription Factors: 
Transcription factors have an important role in gene regulation, tracking the 
expression of these genes can be used as a marker for certain types of cells. The work 
of Yamanaka revealed that it is possible to induce pluripotency to mouse embryonic 
fibroblast by the introduction of four factors: Oct4, Sox2, Klf4 and c-Myc 
(Yamanaka et al., 2006).  
o Octamer-binding Proten 4 (Oct4) 
Oct4 is a member of the POU transcription factors family; it plays a crucial 
role in regulating stem cell pluripotency. Oct4 expression is restricted to embryonic 
stem cells and germ line cells, their expression is maintained in the inner cell mass. 
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Moreover, Oct4 control the expression of other genes such as Sox2, Fgf4, Rex1and 
Utf1, along with the repression of the gene encoding hCG (human embryonic 
gonadotropin) (Pan et al., 2002). 
 
o Sry-related High-mobility Group (HMG) Box-containing (Sox) 
Family  
The Sox family is HMG box transcription factor; they interact functionally 
with POU domain. Sox2 and Oct3/4 are involved in maintaining pluripotency, 
however Oct3/4 is exclusively expressed in embryonic stem cells, and Sox2 is 
expressed in pluripotent, multipotent and unipotent stem cells (Boyer et al., 2005). 
Sox2 is one of the important genes that were initially used for induction of induced 
pluripotent stem cells. Sox2 is expressed in both mouse and human embryonic stem 
cells, and pre-implantation embryos. Besides, sox2 is expressed with Oct4 in post 
migratory primordial germ cells (Yamanaka et al., 2006; Yu et al., 2007). 
o Krupple-like Factor (Klf) Family  
The Klf family is involved in different biological processes, which includes 
proliferation, differentiation, apoptosis and development. The three Cys2 His2 zinc 
fingers, which are located at the C terminus, characterize the Klf family and it is 
separated by a highly conserved H/C link. Klf5 regulates the transcription of both 
Nanog and Oct3/4, it is involved in embryonic stem cells renewal and maintaining 
pluripotency (Ghaleb et al., 2005). Klf2 and Klf4 are also involved in maintaining 
self renewal and pluripotency, besides they regulate the expression of other 
embryonic stem cells transcription factors such as Nanog, Sall4, and Mycn. Studies 
showed that Klfs family members alone are not important for embryonic stem cells 
self-renewal (Jiang et al., 2008; Parisi et al., 2008).  
o Nanog 
Nanog is one of the important transcription factors that play a crucial role in 
maintaining pluripotency in both mouse and human embryonic stem cells. Their 
expression in human embryonic stem cells is much lower than their expression in 
	   7	  
mouse embryonic stem cells (Hatano et al., 2005).  The expression of Nanog is 
downregulated early during embryonic stem cells differentiation; this explains the 
restricted expression of Nanog in embryonic stem cells and their role in maintaining 
pluripotency. Studies showed that Nanog deficient inner cell mass failed to generate 
epiblasts, and results showed that it was able to produce only endoderm like cells 
(Mitsui et al., 2003). Molecular results showed that Nanog mRNA is present in 
embryonic stem cells, not present in differentiated cells, but present in founder cells 
from which embryonic stem cells is derived in preimplantation embryos (Chamber et 
al., 2003).    
o Developmental Pluripotency-associated (DPPA) Genes  
DPPA family consists of 5 proteins, which are related by names only, besides 
they are Oct4 related genes. They are markers for both early embryonic and germline 
pluripotent stem cells (Tanaka et al., 2006). DPPA5, which is also known as ESG1, 
is expressed in embryonic stem cells (Western et al., 2005). Moreover, DPPA3 also 
called “Stella” is expressed in oocytes, preimplantation embryos, embryonic stem 
cells, and primordial germ cells (Du et al., 2010). DPPA4 was found to regulate the 
differentiation of embryonic stem cells to primitive ectoderm lineage (Maldonado-
Saldivia et al., 2007). 
1.4. Ethical Concerns in Embryonic Stem Cells Research 
Embryonic stem cells are derived from the inner cell mass of the blastocysts. 
The blastocyst is formed after 5 days of fertilization. The isolation of embryonic stem 
cells from the inner cell mass causes destruction of the embryo, as a result a lot of 
ethical concerns are against using embryonic stem cells in research. One of the major 
sources of human embryonic stem cells is the spare embryo, which is created for in 
vitro fertilization for infertility treatment. Another source is creating an embryo by 
somatic cell nuclear transfer techniques, only to isolate embryonic stem cells from 
them. Some countries allow the use of the spare embryos as a source for embryonic 
stem cells such as India. Other liberal countries allow the creation of embryos to be 
used as a source for embryonic stem cells. The issue of embryonic stem cells and their 
use in research is still controversial, some people and governments are with and 
others are strictly against (Caulfield et al., 2014).  
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As mentioned previously, the extraction of embryonic stem cells involves 
destruction of an embryo. Two opposing opinions are raised against using embryonic 
stem cells; one side emphasis on the importance of using embryonic stem cells and 
their potential in stopping the pain of a patient, and the other side stresses on the value 
of human life. People see that embryonic stem cells can provide a treatment for 
serious diseases, and using a spare frozen embryo might save a life of another person. 
On the contrary, other people might see that destructing an embryo is against ethics as 
human’s life is of a value that no one should control (Weise, 2013; Doerflinger, 
1999).   
1.5. Somatic Cell Nuclear Transfer 
Briggs and King established the somatic cell nuclear transfer technique to 
study the potential of transplanting an isolated nucleus from late-stage embryos into 
enucleated oocytes (Briggs et al., 1955). At the beginning scientists have been using 
this technique as a tool to study the developmental potential of a cell.  The idea of this 
technique was to remove the nucleus of a recipient egg by a glass needle, the cell 
content of a donor cell is then transferred to the enucleated egg (Briggs and Kind, 
1952). These finding helped the development of Dolly the sheep and other mammals 
from an adult cell (Wilmut et al., 1997). Their results showed that it is possible that 
the genome of a fully differentiated cell to remain genetically totipotent (Gurdon et 
al., 2003; Hochedlinger et al., 2006).  
1.6. Induced Pluripotent Stem Cells (iPSCs) 
Induced pluripotency discovery is built on the following;   (1) the 
development of techniques which gives the chance to scientists to isolate, culture and 
study pluripotent stem cells, (2) studying the effect of transcription factors in 
determining the fate of a cell, these transcription factors’ enforced expression can 
change the fate of one mature cell type into another one, and (3) the technology of 
somatic cell nuclear transfer (Stadtfeld et al., 2012).  The work of Yamanaka and 
Takahashi in 2006 made a great breakthrough in the field of iPS. Their work showed 
that when certain transcription factor are introduced to somatic cells, this cell could be 
reprogrammed to an embryonic-like state.  Yamanaka’s experiment involved 
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screening and identifying 24 pluripotency associated genes that might be used in 
cell’s reprogramming. Their results showed that 4 specific genes could reprogram a 
somatic cell; these genes were Klf4, Sox2, c-Myc, and Oct4. After introducing those 4 
genes, the resulting iPS cells showed morphological and molecular features indicating 
that they are embryonic-like. Besides, these cells generated teratomas in 
immunocompromised mice, and they had the ability to differentiate into the three cell 
lineages. (Yamanaka et al., 2006). Nevertheless, results revealed that the level of 
pluripotency in iPS cells is markedly lower than that of embryonic stem cells.  
 
Using Viral Vectors in iPS 
There are several means to dedifferentiate somatic cells to pluripotent cells; 
induction can be done by using viral vectors, or with no viral vectors by using 
chemical treatment for the cells. There are advantages and disadvantages for each 
method. A considerable amount of work has been carried out in the field of inducing 
pluripotency using viral vectors.  The area of using viral vectors in iPS can be 
subcategorized to 3 different methods; the use of lentiviruses, the use of retroviruses, 
and the use of nonintegrating viruses (O’Doherty et al., 2013). Takahashi and 
Yamanaka’s work described the use of retroviruses in producing the first iPS; the 
used retrovirus was stably integrated into the host genome (Yamanaka et al., 2006). 
From the drawbacks of this technique is the activation of methyltransferases, this 
meant that the corresponding endogenous genes were not activated and the 
reprogramming is incomplete. Besides, the viral transgenes, which was integrated into 
the genome of iPS cells, might cause the formation of tumor in chimeric animals 
(Okita et al., 2007). The use of retroviruses in inducing pluripotency has given a 
highly efficient iPS cells, nevertheless, the risk of tumor formation is an obstacle in 
using iPS cells in clinical settings. A lot of studies have been done in the field of iPS 
in order to over come the issue of tumor formation. Nagawaka et al. have generated 
chimeric mice that survived till day 100 using iPS cells; they have done that without 
using Myc as a factor (Nakagawa et al., 2008). Results revealed that c-Myc was 
found to increase tumor formation when used in reprogramming. However, some 
research was done showing that when using L-Myc,which is a different Myc family 
member, reprogramming was promoted with the risk of tumor formation (Nakagawa 
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et al., 2010). Another method that is used in reprogramming is by using lentiviral 
vectors; it is considered a controlled method of reprogramming. This control is done 
by the drug doxycycline that decreases the risk of transgene expression, allowing only 
the selection of fully reprogrammed cells (Stadtfeld et al., 2008). 
1.6.1. Nonviral method for iPS 
 Results revealed that viral methods of reprogramming are highly efficient, 
nevertheless they were proven to be too risky in order to be used clinically. There are 
various methods that have been put forward in order to overcome the risk of using 
viral methods in reprogramming. One of these methods is transfection of mouse 
fibroblast by two expression plasmids; one plasmid contained cDNA of Oct3/4, Klf4, 
and Sox2, the other plasmid contained c-Myc. This method showed high 
reprogramming efficiency without the risk of using viral vectors and their integration 
into the host DNA. This technique showed high  efficiency which was desirable, they 
proved to be too risky to be used in a clinical setting owing to their insertional 
tendencies. The necessity to find an iPS method that could be used in the clinic was 
then sought after. Various strategies for nonviral reprogramming have been put 
forward and will be discussed in the following section (Okita et al., 2008).  Another 
Nonviral method is using episomal vectors for reprogramming of somatic cells to 
embryonic-like stem cells. In this method fibroblasts is transfected with an episomal 
with Epstein- Barr nuclear antigen-1 which is derived from the Epstein Barr virus. 
This vector was chosen because it can be used in transfection with using viral 
pachaging, moreover it can be removed from cells by a drug selection method 
(Junying et al., 2009). One of the alternative methods for reprogramming is the use 
of small molecules and chemical compounds. The main aim of this method is to 
substitute the use of viral vectors with a cocktail of chemicals or molecules, which are 
used to enhance the process of reprogramming. Results revealed that this method 
could efficiently produce stable iPS free of mutation and integration. This method is 
considered to be safe as it depends on influencing pathways instead of relying on 
genetic modification for cell reprogramming (Lin and Wu, 2015). Nevertheless, 
using chemicals instead of transcription factors in reprogramming results in a 
decreased number of iPS clones, which result in a less yield (Shi et al., 2008). 
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1.7. Derivation of iPSCs from postnatal testis 
Germ cells are unique type of cells as they have the ability to transmit the 
genome from a generation to another. A number of researches emphasize on the 
relationship between embryonic stem cells and early germ cells, as they state that is 
because of naturally occurring pluripotency of embryonic stem cells and the 
totipotency property of germ cells (Zwaka et al., 2005).  
 
A number of researches have been dedicated to the use of cells collected from the 
testis in iPSCs research. Reports have shown that spermatogonial stem cells can be 
transformed by an unknown mechanism in vitro into embryonic like stem cells 
without the use of any viral vectors. This embryonic like stem cells showed similar 
characteristics and expression profile when put in the appropriate culture conditions to 
embryonic stem cells (Skutella and Conrad, 2011). This method overcame the 
ethical concern of using embryonic stem cells and the drawback of using viral vectors 
in induction of pluripotency. The past few years have shown that pluripotent stem 
cells derived from adult testis has a great implication in the field of regenerative 
medicine (De Rooij, 2006). Even though these cells are unipotent, it was found that 
when they are put in certain conditions they give rise to cells that are pluripotent 
(Guan et al., 2006). A lot of studies have reported that it was successful to generate 
embryonic like stem cells from spermatogonial stem cells, these cells were able to 
generate teratomas in immunodeficient mice, they showed similar expression profiles 
to embryonic stem cells, and they are able to differentiate into all germ layers in vitro 
(Kanatsu-Shinohara et al., 2004).  
1.8. Application of iPSCs 
 One of the main difficulties in treating many diseases is the lack of 
information about the mechanisms, which causes disease progression. As a result, 
disease modeling is important in order to develop treatments triggering the main 
cause of the disease. iPSCs is used in disease modeling, as they have the ability to 
function in vitro as well in vivo after transplantation. iPSCs are not only used in 
disease modeling, they are also used in drug discovery, and regenerative medicine as 
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well (Vimal et al., 2015).  
The use of iPSCs in disease modeling is because of their self-renewing 
capabilities along with the ability of these cells to differentiate into all types of cells in 
the human body. Besides, using the patient’s iPSC could be of enormous importance 
as in developing a patient specific therapeutic drug. These cells have been used to 
study the mode of action and mechanism of different diseases such as studying the 
mechanisms, which regulate the differentiation of urinary tract and prostate cells. 
Their results revealed that iPSCs from the previously mentioned sources have better 
efficiency in differentiation than iPSCs derived from skin fibroblast. These findings 
indicate that the organ of origin has a role in the efficiency of differentiation of iPSCs. 
Another important use of iPSCs is in drug discovery and cytotoxicity studies.  
For these studies scientists either use animal models or in vitro animal derived cells. 
However using iPSCs is of better potential as it gives the chance of using the exact 
human cells giving better insight of the exact human physiological conditions and 
their phenotypic attributions (Yoshida and Yamanaka, 2010). Besides, one of the 
drawbacks of using animal models in drug toxicity is that some chemicals might be 
toxic to animals and not to humans. As a result, it is important to test new drugs or 
therapy on human cells to get efficient results. Development of drug testing models 
before being used in clinical trials might reduce costs and safe lives. iPSCs can be 
used to test drug toxicity and side effects. This is fulfilled because they provide a 
similar environment to the human physiology (Seiler et al., 2004). 
One of the important used of iPSCs is in regenerative medicine; it is used in 
treating injured or degenerated tissues. iPSCs offer a good solution as the cells that is 
being transplanted is generated from the patient’s own somatic cells. A number of 
degenerative diseases and injuries can be treated by using iPSCs such as 
musculoskeletal injuries, spinal cord injuries, liver damage, cardiac diseases, and 
hematopoietic disorders (Liu et al., 2011b; Suzuki et al., 2013). 
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1.9. Objectives and Experimental Plan 
 
• The main objective of this study is to establish embryonic-like 
stem cells from adult mouse testis. 
• To achieve our goal, mouse testis was harvested and 
enzymatically digested into single cell suspension cultured under 
specific culture conditions that promote the development and 
survival of pluripotent stem cells.  
• The established embryonic-like stem cells were characterized at 
the molecular and histological levels. 
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2. Materials and Methods 
 
2.1. Isolation of germ cells from adult males testes 
Most of the procedures performed as regard isolation, harvesting, 
dedifferentiation of germ cells to embryonic like stem cells were done in reference to 
the work of (Golestaneh et al., 2009). We obtained mouse testes from 15 adult male 
CD-1 Swiss albino mice (8-10 weeks).  Internationally valid guidelines were used in 
all animal experiments that were carried out. Three independent experiments were 
performed; each experiment utilized three mice. Mice were euthanized and dissected; 
testes were isolated and placed in Dulbecco’s Modified Eagle Medium (DMEM, 
GIBCO, USA). Testes were then washed in sterile Phosphate Buffered Saline (PBS) 
(Lonza, Switzerland) in six well plates. In each experiment, mice testes (3 mice) were 
collected and placed in 100mm cell culture dish (Corning, USA) with serum-free 
DMEM. Testes were then decapsulated and enzymatic digestion was performed over 
two steps; the first step was with collagenase IV (Worthington Biochemical Corp, 
USA) with concentration of 1mg/mL, cells were incubated for 20 minutes in CO2 
incubator (Shallab, USA) with temperature adjusted to 37 °C. Cells were then washed 
with PBS and centrifuged at 300xg for 10 minutes at 15-20 °C. The second step of 
digestion was done by adding hyaluronidase (Sigma), trypsin (GIBCO, USA), and 
collagenase IV with concentration 1.5, 1.1 mg/mL respectively to the isolated 
seminiferous tubules.  The cells were again incubated at 37° C but for 20 minutes. 
Adding serum-containing medium then inactivated trypsin; cells were again washed 
by PBS and centrifuged at 300xg for 10 minutes. These steps were performed to 
obtain individual cells for primary cell culture. 1 ml of the cell suspension is collected 
to be used in molecular testing, pathology & cytology, and flow cytometry. This 
sample is referred as sample collected at “Day 1”.  
Before proceeding to culturing of cells collected from the testis cell count and 
viability were performed by trypan blue exclusion staining. In order to perform viable 
cell count test, 20 µl cells were added to 20 µl 0.4% trypan blue (Sigma, USA), cells 
were counted using a hemocytometer (Hausser Scientific, USA). 
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2.2. Dedifferentiation of germ cells to embryonic like stem cells. 
 
  Cells collected from the testis were cultured in six well plate dishes that were 
gelatin coated.  The seeding density of the cells was 200,000 cell/cm2. Preparation of 
0.1% gelatin was done by adding 0.5 g gelatin powder to 500 ml endotoxin-free 
water, and then the mixture was autoclave for 30 minutes. 0.1% gelatin was then left 
to cool at room temperature. 2 ml of 0.1% gelatin was added to each well of six well 
plates, gelatin is left in the wells for 1 hour. Gelatin is then discarded and the wells are 
left for two hours to dry.  For each well a mixture of germ cells with 15% knockout 
serum replacement for ES cells (Gibco, USA), Knockout DMEM (Gibco, USA), 0.1 
µM β-mercaptoethanol (β-ME, 10 mM, Serva, Germany), 1× penicillin–streptomycin 
(Gibco, USA), 2 mM l-glutamine (Gibco), 100× nonessential amino acids (NEAA, 
Gibco, USA), 10 ng/mL, recombinant mouse fibroblast growth factor basic (bFGF, 
Gibco, USA), and 0.12 ng/mL recombinant mouse transforming growth factor β3 
(TGF-β, Gibco, USA). After 5 days colonies of small embryonic like stem cells 
started to be formed. After a week of culture, cells started reaching 80-90% 
confluency; cells were trypsinized by trypsin/EDTA and they were cultured in new 
six well gelatin coated plates. This was repeated weakly up to eight weeks. Media 
were changed twice a week with the same mixture mentioned previously.  Cells were 
regularly examined by using inverted microscope (Olympus 1X70, USA) to monitor 
and characterize their morphology. 
2.3. Reverse Transcription- Polymerase Chain Reaction analysis 
 
Molecular testing was performed at day 1 of cells collected from the testis and 
at day 14, which is the end of the dedifferentiation cycle. Total RNA was extracted 
from cell pellets at day 1 and day 14 using Trizol (Invitrogen, USA) as per 
manufacturer’s protocol. RNA was dissolved in diethylpyrocarbonate (DEPC) water. 
RNA was then qualified using Shimadzu spectrophotometer UV-1800 at A260mm. 
Synthesis of cDNA was done from 1 µg RNA using RevertAID cDNA synthesis kit 
(Fermentas, USA) as per manufacturer’s protocol. β actin was used as an internal 
control. For each reaction mixture, 1 µl of cDNA was added to 1 µM of each mouse 
specific reverse and forward primers. The used primers for molecular analysis were 
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Vasa, Nanog, cripto TDGF1, Esg1, and Thy1. The reaction also contained 2 µl 10X 
DreamTaq Buffer, 1 µl of 10 mM dNTP, and 1 U of DreamTaw DNA Polymerase 
(Fermentas Inc, USA). To complete the reaction nuclease free water was added to 
form a total mixture of 20 µl. Each primer had its primer specific cycle programs; 
PCR machine used for this test was a Verti Thermal Cycler (Applied Biosystems, 
USA). The sequences of each primer along with, their amplicon size, annealing 
temperature, and number of PCR cycles required is mentioned in table 1.  PCR 
products were electrophoresed on 2% agarose gel. Ethidium bromide (Sigma, USA) 
was added to the gel during preparation to visualize the bands. Each gel was 
photographed under UV light using GelDoc (Biorad, USA). ImageJ software (NIH, 
USA) was used in assessment of the bands.  
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Table 1 Primers used in the study 	  
	  
 
 
Gene                         Sequence Amplicon 
Size 
Annealing 
Temperature 
No. of 
PCR 
cycles 
Reference 
Mouse 
Vasa 
F-5’GGTCCAAAAGTGACATATATACCC3’ 
R-5’TTGGTTGATCAGTTCTCGAGT3’ 
 
420 bp 57°C 25 Toyooka Y. et al., 
2000. Expression and 
intracellular localization 
of mouse Vasa-
homologue protein 
during germ cell 
development. 
 
Mouse  
Nanog 
 
 
F-5’GGCTGCCCTCTCCTCGCCCTT3’ 
R-5’CCAAGGCTGGCCGTTCCAGG3’ 
 
583 bp 
 
66°C 
 
35 
 
 
Mouse 
cripto 
TDGF1 
 
 
F-5’ATGGACGCAACTGTGAACATGATGTTCGCA3’ 
R-5’CTTTGAGGTCCTGGTCCATCACGTGACCAT3’ 
 
174 bp 
 
58°C 
 
35 
Takahashi K. and S. 
Yamanaka. 2006. 
Induction of pluripotent 
stem cells from mouse 
embryonic and adult 
fibroblast cultures by 
defined factors.  
 
 
Mouse 
Esg1 
 
 
F-5’GAAGTCTGGTTCCTTGGCAGGATG3’ 
R-5’CTCGATACACTGGCCTAGC3’ 
 
376 bp 
 
58°C 
 
35 
Takahashi K. and S. 
Yamanaka. 2006. 
Induction of pluripotent 
stem cells from mouse 
embryonic and adult 
fibroblast cultures by 
defined factors.  
 
 
Mouse 
Thy1 
 
 
F-5’GCCGCCATGAGAATAACA3’ 
R-5’GCCGCCATGAGAATAACA3’ 
 
753 bp 
 
60°C 
 
45 
 
 
Mouse  
B-actin 
 
 
F-5’ACGCAGGATTTCCCTCTCAGC3’ 
R-5’GGCCCAGAGCAAGAGAGGTAT3’ 
 
460 bp 
 
60°C 
 
27 
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2.4. Immunophenotyping by Flow Cytometer 
Aliquots were taken on day 1 after harvesting of cells from the testes, and on 
day 14 of culturing cells collected from the testis. Cells from day 14 were collected 
after trypsinization for 5 min at 37°C, cells were then recovered by centrifugation at 
500xg for 5 mins. Cells were then washed with 2 ml phosphate buffer saline and 
followed by vortex, and centrifugation step. For each reaction the specific antibody 
was added and incubated fro 20 min in the dark at 4°C. Cells were washed again with 
phosphate buffer saline, and analyzed on a COULTER Epics XL flowcytometer 
(Beckman Coulter, Mexico) and data acquisition and analysis were performed using 
XL System II software. A list of the cluster of differentiation surface markers used in 
flowcytometer analysis is in table 2 along with the function of each. 
Table 2 CD surface markers used in Flowcytometer analysis 
 
CD Marker 
 
Function 
 
CD 90 (Thy1) 
 
Mouse embryonic stem cells 
 
CD 15 (SSEA-1) 
 
 
Mouse embryonic stem cells  
& Mouse germ cells 
 
CD117 (c-kit) 
 
 
Mouse embryonic stem cells  
& Primordial germ cells 
 
CD133 
 
Mouse embryonic stem cells 
 
SOX2 
 
Mouse embryonic stem cells 
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2.5. Statistical Analysis  
 
Data presented are collected from three independent experiments. 
Comparisons were carried out using one-way analysis of variance (ANOVA). 
Statistical analysis was performed and plotted using GraphPad Prism software version 
5 (GraphPad Software, USA). 
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3. Results 
 
3.1. Cellular characterization of cells collected from the testis  
The main objective was to derive embryonic-like stem cells from mice testis.. 
Mice were sacrificed in three independent experiments, and then the testis was both 
mechanically agitated and enzymatically digested. Cells collected from the testis were 
obtained devoid of connective tissue cells and interstitial components and cultured in 
defined media designed for embryonic stem cells. The viable cell count of the cell 
suspension was an average of 2 x106 in each culture plate, and the average rate of 
viable cells was 91% suggesting that the majority of the recovered cells were viable. 
It was critical to use a well-defined culture medium. This media is important for 
optimal derivation and maintenance of cells isolated from the testes, and to maintain 
the undifferentiated conditions and induce their reprogramming towards being 
embryonic-like stem cells. 
After culturing the testicular cells for 24 h, they started to adhere to the surface 
of the culture plate. Using the inverted microscope to analyze the morphology of the 
cells, they were seen round or oval in shape with a little cytoplasm and a large nucleus 
as shown in figure 1. The cultured cells tended to form small colonies; each colony 
was 3-5 cells.  
                                                      
 
                                           
                             
 
Figure 1 Cellular characterization of germ cells at day 1. Adherent cells at day 1 
after harvesting of testicular, cells are all round shaped with different sizes of cells 
indicating there are different cell types (x20). Round spermatids (arrow) 	  	  	  	  	  
A	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3.2. Dedifferentiation of adult testicular cells into embryonic-like stem cells 
At day 4, cells started to form packed colonies of embryonic-like stem cell; 
these colonies became multilayered with clear boundaries appearing under the 
inverted microscope. Colonies were successfully expanded and passaged to up to 8 
passages. The phenotype of those grown embryonic-like stem cells at day 4-14 
resembles those of mouse embryonic stem cell colonies (Figure 2). What was 
significant to notice that these cells were very resistant to disaggregation by 
trypsin/EDTA based reagent, and it took more time for their disaggregation during 
subculture steps. It was noted that after day 14 the growth of embryonic like stem 
cells colonies started to decrease to reach the least at day 50. 
 
 
 
 
 
 
 
 
 
        Figure 2 Morphological examination of cultured embryonic-like stem cells. 
(A)&(B) Showing a colony of embryonic-like stem cells (arrowheads)	  at day 7 
(x40). (C)	  The	  only	  surviving	  cell	  type	  is	  the	  embryonic-­‐like	  stem	  cells	  which	  formed	  a	  colony	  (arrowheads)	  (x20).	  (D)	  Colonies	  of	  embryonic-­‐like	  stem	  cells	  at	  day	  14	  showing	  only	  few	  colonies	  with	  an	  increase	  in	  the	  number	  of	  colonies.	  	  	  	  
B	  
C	   F
G
	  
A	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3.3. Expression patterns of cells collected from the testis at the RNA level 
For further analysis of testicular cells at day 1, RT-PCR was performed to test 
the expression of cells collected from the testis and embryonic stem cells markers. 
As shown in figure 3 a high expression of VASA, a germ specific-marker, whereas 
embryonic stem cells markers such as Nanog, ESG1, cripto TDGF1, and Thy1 were 
not expressed at the RNA level from cells collected at day 1 (Figure 3, 4, 5, 6, 7). 
VASA gene, which is strictly expressed in gonads, and undetectable in somatic cells, 
is uses as a marker used for germ cells.  VASA was not detected in embryonic-like 
stem cells (ESC-like) (Toyooka et al., 2000). 
 
 
 
 
 
  
                        
 
 
 
 
 
 
 
 
Figure 3 Expression of VASA surface marker in testicular cells and embryonic-
like stem cells by RT-PCR. (A) Representative RT-PCR gel image for the loading 
control β-actin (460 bp) and VASA (420 bp). gel 1 is for day 1 testicular cells and day 
7 embryonic-like stem cells, gel 2 is for day 1 and day 14 embryonic-like stem cells, 
and gel 3 is for the internal control(B) Bar chart representing normalized expression 
of VASA relative to loading control. Data is collected from three independent 
experiments. 
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3.4. Expression patterns of embryonic stem cell markers at the RNA level 
We examined the expression of a number of embryonic stem cells markers in 
testicular cells and embryonic-like stem cells. As shown in figure 4 Nanog is strongly 
expressed in embryonic-like stem cells and not expressed in the testis. Nanog is one 
of the transcription factors, which have a role in pluripotency of the cell.  
 
 
 
 
 
 
    
       
 
 
 
 
 
 
 
 
 
Figure 4 Expression of Nanog surface marker in the testis and embryonic –like 
stem cells by RT-PCR. (A) Representative RT-PCR gel image for the loading 
control β-actin (460 bp) and Nanog (583 bp). gel 1 is for day 1 testis and day 7 ESC-
like, gel 2 is for day 1 and day 14 ESC-Like, and gel 3 is for the internal control (B) 
Bar chart representing normalized expression of Nanog in relative to loading control. 
Positive control is collected from spleen. Data is collected from three independent 
experiments. 
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One of the surface markers of embryonic stem cells is Thy1. Results revealed 
that the expression pattern of Thy 1 is slightly higher in embryonic-like stem cells 
than cells collected from the testis at day 1. Figure 5 reveals expression pattern of 
Thy1 from testis and embryonic-like stem cells from three independent experiments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Expression of Thy1 surface marker in the testis and embryonic –like 
stem cells by RT-PCR. (A) Representative RT-PCR gel image for the loading 
control β-actin (460 bp) and Thy1 (166 bp). (B) Bar chart representing normalized 
expression of Thy1 in relative to loading control. Positive control is collected from 
spleen. Data is collected from three independent experiments. 
 
 
Another embryonic stem cells marker is ESG1 (also known as DPPA). They 
are a marker for early embryonic stem cells. Figure 6 reveal the expression of ESG1, 
which is 2 folds higher in embryonic-like stem cells than cells collected from the 
testis. 
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Figure 6 Expression of ESG1 surface marker in the testis and embryonic –like 
stem cells by RT-PCR. (A) Representative RT-PCR gel image for the loading 
control β-actin (460 bp) and ESG1 (376 bp). (B) Bar chart representing normalized 
expression of ESG1 in relative to loading control. Positive control is collected from 
lung. Data is collected from three independent experiments. 
 
For further molecular analysis, cripto TDGF1 was tested; it is a gene, which 
encodes a growth factor, which is related to epidermal growth factor. It has a role in 
embryogenesis and is a marker for embryonic stem cells.  As shown in figure 7 
expression of cripto TDGF1 is higher in embryonic-like stem cells than cells collected 
from the testis. 
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Figure 7 Expression of cripto TDGF1 surface marker in the testis and embryonic 
–like stem cells by RT-PCR. (A) Representative RT-PCR gel image for the loading 
control β-actin (460 bp) and cripto TDGF1 (174 bp). (B) Bar chart representing 
normalized expression of cripto TDGF1 in relative to loading control. Positive control 
is collected from spleen. Data is collected from three independent experiments. 
 
 
3.5. Immunophenotyping by Flow Cytometer 
Immunophenotyping was performed on testicular cells isolated from mice 
testes at day 1 and embryonic-like stem cells at day 14. CD antigens are surface 
proteins, which belong to different classes as glycoproteins, receptors and integrin; 
different cell types have different antigens. Antibodies can be used to recognize CD 
antigens on the surface of the cells and are used as a tool in cell sorting and cell 
identifying. In our study the markers used in the FACS analysis were CD 90(Thy1), 
CD 15 (SSEA-1), CD117 (c-kit), CD133, and SOX2; most of them are markers 
present on the surface of embryonic stem cells. As shown in table 3 there is a 
significant increase in the count of cells with the embryonic stem cells markers. There 
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was an increase by ≈ 1.7 folds in CD 90 (Thy1), there was a higher increase in CD 15 
(SSEA-1) marker by ≈ 8.2 folds, CD 117 (c-kit) by ≈ 6.18 folds, CD 133 by ≈ 5.14 
folds, and finally SOX2 with an increase of ≈ 2.9 folds. When comparing results as 
shown in figure 3 there is a significant increase in all embryonic stem cells markers, 
which shows that germ cells are dedifferentiated to be embryonic-like stem cells 
expressing the markers listed below. Figure 3 shows the significant increase in the 
count of embryonic stem cells marker from day 1 to day 14.  
Table 3 Count means of each CD surface marker used in Immunophenotyping of 
cells from the testis and embryonic-like stem cells. Data presented as percentage 
means of day 1 and day 14 ±SD of three independent experiments. 
 
Surface Marker 
 
Count on day 1 
 
Count on day 14 
 
CD 90(Thy1) 
 
2,068±1,272 
 
3,665±4,282 
 
CD 15 (SSEA-1)  2,863±1,787  23,569±26,596 
 
CD117 (c-kit)  2,669±1,666  16,518±18,795 
 
CD133  4,745±2,691  24,404±27,424 
 
SOX2  3,324±2,723  9,746±10,573 
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Figure 8 Immunophenotyping of cell from the testis and embryonic-like stem 
cells. Bar charts representing counts of cells bound to embryonic stem cells markers 
at day 1 and day 14. Data are presented as ±SD of three independent experiments. 
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Figure 9 Immunophenotyping of germ cells and embryonic-like stem cells. 
Flowcytomeric analysis with FITC CD 90, FITC CD 15, PE CD117, PE CD133, and 
PE SOX2. Row A represent germ cells at day 1 with different markers, row B is 
embryonic-like stem cells at day 14 with different markers. 
A	   B	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4. Discussion  
 
Embryonic stem cells is considered to be the most promising source for cell based 
therapy in the field of regenerative medicine, these cells can give rise to all three germ 
layers. Nevertheless, embryonic stem cells have some drawbacks; one of them is the 
ethical and legal controversy that is associated with their collection. In order to avoid 
such problem, generation of induced pluripotent stem cells from somatic cells through 
various techniques has been well established. These techniques are such as somatic 
cell nuclear transfer or directly reprogramming the cells by introducing embryonic 
stem cells genes. Although these techniques have been well studied and offer a great 
potential use in the field of regenerative medicine, yet, they do have some 
complications. For instances, by examining the developed embryos from the nuclear 
transfer technique, the embryonic stem cells were found to carry both genetic 
information from both; the somatic cell and the new embryo. (Beyhan et al., 2007; 
Fan et al., 2011; French et al., 2008; Tachibana et al., 2013; Yang et al., 2007).  
 
Induced pluripotent stem cells was introduced by Shinya Yamanaka and his team 
in 2006, the developed induced pluripotent stem cells by introducing 4 factors: Klf4, 
Oct4, Sox2 and c-myc to mouse somatic cells. They have performed the same 
technique using somatic human cells instead in the year 2008, and they have 
succeeded in generating induced pluripotent stem cells from them too. A number of 
scientists have performed the same technique using different somatic cell types and 
different systems. However, these genes were introduced by viral vectors, this raised a 
question of the safety of this technique. The fact of adding these genes, as some of 
them are cancer causing, along with the fact that the viral vector might integrate to the 
host genome, made these cells precluded from being used in regenerative medicine. A 
number of researches have been dedicated to overcome the use of cancer causing 
genes and viral vectors in order to be able to generate iPS cells to use these cells 
safely for patients (Okita et al., 2007; Park et al., 2008; Takahashi & Yamanaka, 
2006; Yu et al., 2007). 
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Another technique that has been used is using cells isolated from the testis 
to be reprogrammed to embryonic like stem cells. The ability of reprograming of 
adult mouse germ cells into pluripotent stem cells has a great potential to be used 
an animal model so it can be used later on in reprogramming human testis that can 
be used in the field of regenerative medicine. Although cells collected from the 
adult testis are unipotent and their differentiation is restricted to gametes 
generation under normal conditions, it was found that when these cells are placed 
in certain culture conditions they have the ability to give rise to cells that are 
pluripotent (Guan et al., 2006; Kanatsu-Shinohara et al., 2004; Matsui et al., 
1992; Sabine et al., 2008). Different techniques have been reported using cells 
isolated from the testis to generate pluripotent stem cells, it was reported that 
primordial germ cells could give rise to embryonic like stem cells when cultured 
in appropriate conditions. These embryonic like stem cells were reported to have 
similar properties to embryonic stem cells that are isolated from the inner cell 
mass (Resnick et al.,1992; Turnpenny et al.,2004).  
 
We have isolated cells from adult mice testis; the total number of mice 
used was 15 mice. Enzymatic and mechanical dispersion was done in order to end 
with single cell culture, devoid from interstitial components (Bellve et al., 1977; 
Dym et al., 1995). After the isolation step, cells from the testis we recultured in 
defined culture media, which is designed for the culture of mouse embryonic stem 
cells (Golestaneh et al., 2009; Guan et al., 2006; Kanatsu et al., 2004; Kubota 
et al., 2006; Matsio et al., 1992). Some protocols use feeder layers to maintain 
the growth of embryonic stem cells such as mouse embryonic fibroblast, these 
feeder layers permit the continuous growth in an undifferentiated state (Amit el 
at., 2003; Kanatsu-Shinohara et al., 2007). Other culture systems for embryonic 
stem cells have been established without the use of feeder cells, the advantage of 
not using feeder cells is to reduce exposing the embryonic stem cells to animal 
pathogens. Furthermore, growing embryonic stem cells without feeder cells give a 
safer yield to be used for future clinical application (Amit et al., 2004; Hong-mei 
et al., 2006; Levenstein et al., 2006; Ludwig et al., 2006). In our study we have 
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grown our embryonic-like stem cells without feeder cells, however we have 
prepared our six well culture plates coated with gelatin to help cells to adhere.  
 
After the enzymatic digestion of the testis we obtained a mixture of 
somatic and germ cells, this is shown in figure 1. Our results at day 1 which is 
shown in figure 1 shows a mixture of single cell suspension with cells of different 
sizes and shapes including spermatozoa, spermatids and sertoli cells.  Cells at day 
1 grew separate from each other without forming colonies.  As shown in Figure 1 
cells have round nucleus with very small cytoplasm. In our protocol we did not 
separate spermatogonial stem cells from the testis or any other germ cells before 
the dedifferentiation process, as we have grown the whole mixture for 
dedifferentiation. Other protocols pre-select spermatogonial cells with magnetic 
activated cell separation (MACS); these cells are selected using markers such as 
CD49f, CD90, or GDNFR-a1. The selection step is performed before the addition 
of the designed culture media for the dedifferentiation step (Kabouta et al., 2004; 
Shinohara et al., 1999; Stukenborg et al., 2007). Our results showed 
comparable results than that with the pre-selection before the culture of the cells, 
(Meng et al., 2000; Shamblott et al., 1998; Shamblott et al., 2001; Costoya et 
al., 2004). Some protocols use collagen and laminin coat for the wells in order to 
select spermatogonial cells pre-dedifferentiation step, this is done to end with a 
highly pure spermatogonial cells (Hamra et al., 2004). As shown in figure 2 
colonies of cells started to be formed from day 7, cells at day 7 started to be larger 
in size with a big dark nucleus and small cytoplasm. Cells kept on forming 
colonies from day 7 up to day 38, however the optimum time for the growth of the 
embryonic-like stem cells were between day 7-21. Our results were comparable to 
the results of Golestaneh, however their results showed colonies formation up to 
day 60 (Golestaneh et al., 2009). 
 
Molecular analysis of the isolated cells from the testis showed that these 
cells changed their characteristics, loosing their germ cells properties and acquired 
embryonic stem cells characteristics on the morphology level along with their 
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expression pattern. These cells started to act more like embryonic stem cells 
starting from day 7, losing their germ cells properties (Brinster et al., 1994; De 
Rooij et al., 2006;Ginis et al., 2004; Meissner et al., 2007; Wernig et al., 2007). 
At day 1-isolated cells showed the expression of VASA; which is a germ cell 
marker. As shown in figure 3 VASA was expressed at day 1, however starting 
from day 7 till day 14 these cells did not express VASA.  
 
Isolated cells from day 1 were tested for the expression of embryonic stem 
cells markers such as Nanog, Thy1, ESG1, and cripto TDGF1. As shown in figure 
4 Nanog was not expressed at day 1, however their expression started at day 7 and 
at day 14. Comparable results showed the discrete expression of VASA at day 1 
and the expression of NANOG only after day 7 (Golestaneh et al., 2009; Okita 
et al., 2007; Parker et al., 2008; Yu et al., 2007; Zaho et al., 2012). Nanog is 
considered one of the key transcription factors, which have a role in maintaining 
pluripotency along with self-renewal. Nanog was one of the transcription factors 
used by Yamanaka to induce pluripotency to somatic cells, and was proven to 
have a role in maintaining stemness (Chambers et al., 2003; Hatano et al., 2005; 
Mitsui et al., 2003). Our results showed that Nanog is strictly expressed in 
embryonic stem cells and not in germ cells. However other results showed high 
expression of Nanog in primordial germ cells of E11.5 and E12.5 (Yamaguchi et 
al., 2005) and in juvenile mouse testis as observed in our laboratory. Another 
embryonic stem cells marker that was used is Thy1; figure 5 shows that Thy1 is 
expressed both at day 1 and day 14. This might be explained that Thy1 is 
expressed also in different somatic cells and is a marker for hematopoietic stem 
cells. The cultured cells at day 1 are a mixture of different types of cells including 
hematopoietic stem cells. However the expression pattern increased slightly at day 
14 than day 1 because the growth of embryonic-like stem cells than other cell 
types because of the media present which is suitable for the growth of embryonic 
stem cells (Draper et al., 2002; Xu et al., 2001).  
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Moreover, other embryonic stem cells markers were studied such as 
ESG1. ESG1 is considered one of the potential markers for embryonic stem cells, 
however they are also expressed in primordial germ cells, which is present in the 
mixture collected at day 1 (Tanaka et al., 2006; Western et al., 2005). 
Expression of ESG1 was higher at day 14 than at day 1 as shown in figure 6. 
Another embryonic stem cells marker that was used is cripto TDGF1; it does have 
a critical role during embryogenesis. Our results showed in figure 7 that it is also 
expressed both at day 1 and at day 14. This marker is also expressed in other 
somatic cells such as cardiomyocytes and fibroblast cells (Lonardo et al., 2010). 
These results reveal that the marker that was strictly expressed in cells of day 1 
was VASA, as for the embryonic stem cells Nanog was solely expressed at day 7 
and 14.  
 
Beside molecular analysis, flow cytometer analysis was performed on the 
cells at day 1 and day 14. Figure 9 shows the count of cells in relationship with 
the used embryonic stem cells surface marker. Starting with CD90 which is 
expressed both in embryonic stem cells and hematopoietic stem cells, the figure 
show the expression of CD90 both at day 1 and at day 14 with a slight increase at 
day 14. However, for CD15, cd117, and CD133 expression at day 14, they 
increased significantly. Similar results showed the expression of these markers in 
embryonic stem cells, and the minimal expression of these markers in some types 
of somatic cells such as cells from the testis (Henderson et al., 2002; Sundberg 
et al., 2009). Last, SOX2; which is one of the key markers for embryonic stem 
cells, their expression increased by more than 2 folds from day 1 to day 14. 
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5. Conclusion  
 
 
In conclusion, testicular cells from adult mouse testis can be isolated and 
cultured in certain designated culture media so that they can dedifferentiate to 
embryonic-like stem cells. When these cells are maintained under embryonic stem 
cells culture condition they start to form colonies of embryonic-like stem cells 
both in morphology and in their molecular expression. Dedifferentiating germ 
cells to pluripotent stem cells can be used later on with human cells in order to be 
used in regenerative medicine in order to treat a wide range of diseases such as 
Parkinson’s and other incurable diseases. Nevertheless, further investigation is 
required in order to make sure these cells are safe to be used clinically. Moreover, 
studying the morphology, genetic imprinting, genetic stability and gene 
expression of these cells is important before being used in humans. Additionally, 
more studies should be done to differentiate these cells into different germ 
lineages. These studies will facilitate providing essential data for potential clinical 
applications.  
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